Quidel | QDEL - Selling And Administration Expenses

Stock Price
28.07
Daily Change
0.42 1.52%
Monthly
-6.62%
Yearly
-34.32%
Q1 Forecast
26.33

Quidel reported $186.9M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.13B 125M Dec/2025
Agilent USD 428M 37M Sep/2025
Avanos Medical USD 77.6M 5.9M Sep/2025
Becton, Dickinson and Co. USD 1.37B 46M Sep/2025
Bruker USD 242.5M 11.1M Sep/2025
Charles River Laboratories USD 177.59M 8.23M Sep/2025
Danaher USD 2.03B 35M Dec/2025
Exact Sciences USD 491.64M 35.94M Sep/2025
Haemonetics USD 101.62M 10.37M Sep/2025
Hologic USD 2.5B 2.24B Dec/2025
Illumina USD 256M 59M Sep/2025
IQVIA Holdings USD 514M 5M Sep/2025
Merit Medical Systems USD 107.38M 5.72M Sep/2025
Mettler Toledo International USD 248.39M 1.09M Sep/2025
Myriad Genetics USD 129M 1.3M Sep/2025
Neogen USD 107.5M 1.56M Sep/2025
Quidel USD 186.9M 16.8M Sep/2025
Revvity USD 241.91M 9.6M Sep/2025
STAAR Surgical USD 59.38M 18.08M Sep/2025
Thermo Fisher Scientific USD 1.98B 182M Dec/2025
Waters USD 214.23M 12.97M Sep/2025